Related Experiment Videos
Tools to assess (and achieve?) long-term asthma control
1Université de la Méditerranée, Hôpital Ste Marguerite, Marseille, France. antoine.magnan@mail.ap-hm.fr
Respiratory Medicine
|October 16, 2004
Summary
Monitoring asthma control requires reliable tools. Exhaled nitric oxide and sputum eosinophilia effectively predict exacerbations, enabling proactive management and long-term asthma control.
Area of Science:
- Pulmonology
- Allergy and Immunology
Background:
- Effective asthma control monitoring is crucial for preventing exacerbations and guiding treatment adjustments.
- Current methods like clinical symptoms and lung function tests are often reactive, detecting changes only after symptom onset.
Purpose of the Study:
- To identify reliable, non-invasive biomarkers for early detection of asthma exacerbations and long-term control.
- To evaluate the predictive value of various asthma assessment tools.
Main Methods:
- Review of current asthma assessment tools including clinical parameters, lung function, Asthma Control Questionnaire (ACQ), sputum eosinophilia, and exhaled nitric oxide (NO).
- Comparison of the predictive capabilities of these tools for asthma exacerbations.
Main Results:
- Clinical symptoms, lung function, and ACQ are inadequate as they change concurrently with symptom manifestation.
- Sputum eosinophilia and exhaled NO concentrations are predictive of asthma exacerbations, allowing for early intervention.
- These biomarkers aid in achieving and maintaining long-term asthma control.
Conclusions:
- Sputum eosinophilia and exhaled NO are superior markers for monitoring asthma control and preventing exacerbations.
- These non-invasive methods support proactive asthma management and long-term patient well-being.